Lipoedema
Can Ozempic®️, Wegovy®️, or Mounjaro®️ actually make your legs thinner?
Since the introduction of medications such as Ozempic®️, Wegovy®️, and Mounjaro®️, many women with lipedema have been asking themselves the same question:
"If I lose a lot of weight thanks to these treatments, will my lipedema finally go away?"
That is a perfectly legitimate question.
In some patients, the first few kilograms lost are accompanied by a visible reduction in waist, arm, or even leg circumference. In others, the upper body slims down quickly, while the lower body shows little change, sometimes giving the impression that the imbalance is becoming even more pronounced.
The reality is more nuanced than a simple “yes” or “no.”
The latest scientific findings show that significant weight loss can reduce the volume of tissue affected by lipedema, but this does not mean that the condition goes away. Pain, tenderness, a tendency to bruise, and fibrosis may persist despite dramatic weight loss.
Understanding this difference is essential to avoid unrealistic expectations and choose the most appropriate treatment.
⸻
Key points to remember
Current scientific data already provides answers to several questions.
✅ Significant weight loss can reduce the size of the legs in some patients.
✅ GLP-1 therapies often improve metabolic health.
✅ Some women also notice an improvement in their mobility.
❌ However, no medication has yet been shown to cure lipedema.
❌ Treatments such as Ozempic®️, Wegovy®️, or Mounjaro®️ are not a substitute for specialized care.
⸻
Ozempic®️, Wegovy®️, and Mounjaro®️: What's the difference?
These three medications belong to a class of drugs that alter appetite regulation and improve glucose metabolism.
They affect hormones naturally produced by the body after meals, which help reduce feelings of hunger and slow stomach emptying.
Although these treatments are often mentioned together, they are not used for exactly the same conditions.
Ozempic®️
Ozempic®️ contains semaglutide.
In France and the European Union, it is primarily indicated for the treatment of type 2 diabetes.
The weight loss observed in many patients is a significant effect of the treatment, but Ozempic®️ is not officially marketed as a medication for treating obesity.
⸻
Wegovy®️
Wegovy®️ also contains semaglutide.
The main difference lies in its indication and dosage.
This is a medication specifically developed for the medical management of obesity and overweight when they are associated with certain complications.
⸻
Mounjaro®️
Mounjaro®️ contains tirzepatide.
Unlike semaglutide, this molecule acts simultaneously on two hormone receptors:
• GLP-1;
• GIP.
This dual mechanism explains the sometimes very significant weight loss observed in clinical trials.
⸻
Do these medications treat lipedema?
The answer is clear:
No.
To date, none of these treatments has been specifically approved for the treatment of lipedema.
When prescribed for a patient with lipedema, their purpose is generally different:
• treat obesity;
• treat type 2 diabetes;
• improve certain metabolic complications associated with being overweight.
In other words, these medications do not directly target the biological mechanisms responsible for lipedema.
On the other hand, the weight loss they promote may indirectly affect the course of the disease in some patients.
That is precisely what researchers are trying to understand better today.
⸻
Can lipedema really be reduced by losing weight?
For many years, a widely held belief stated that:
"The fat associated with lipedema never decreases, even when you lose weight."
The most recent research shows that this statement is probably too categorical.
A study published in 2025 followed women who had both lipedema and obesity.
After losing about 9% of their body weight, the researchers observed a decrease in abdominal fat… as well as in fat in the legs.
In other words, the tissues affected by lipedema did not appear to be completely resistant to weight loss.
This finding represents a significant advance in our understanding of the disease.
It shows that medically supervised weight loss can lead to a real reduction in the volume of the lower limbs in some patients.
⸻
But why doesn't lipedema go away?
This is probably the most important concept to understand.
Lipedema is not simply a buildup of fat.
This is a complex chronic disease involving several mechanisms:
• abnormal proliferation of adipose tissue;
• low-grade chronic inflammation;
• progressive tissue fibrosis;
• microcirculatory abnormalities;
• fragility of small blood vessels;
• occasional disturbances in lymphatic drainage;
• painful hypersensitivity of the subcutaneous tissue.
Losing fat, therefore, is not necessarily enough to correct all of these mechanisms.
That is exactly what current studies show.
In some patients, the volume of the legs decreases, while pain, tenderness, or fibrosis persist.
This distinction is crucial: improving the volume does not mean curing the disease.
Scientific studies: What do the available data actually show?
The advent of GLP-1 receptor agonists has profoundly changed the management of obesity. The weight loss observed is sometimes dramatic, which naturally raises a question among patients with lipedema: Does the disease progress in the same way when weight is lost?
For a long time, knowledge was based primarily on clinical experience. In recent years, several scientific studies have begun to provide more objective answers.
Although there are still relatively few studies, they already provide a better understanding of what we can reasonably expect… and what we cannot expect.
⸻
Can losing weight actually make your legs look smaller?
Yes.
Contrary to a long-held belief, tissue affected by lipedema does not appear to be completely resistant to weight loss.
A study published in 2025 followed nine women who had both obesity and lipedema. After a nutritional intervention that resulted in a weight loss of approximately 9% of their body weight, the researchers observed several interesting changes.
As expected, the participants lost abdominal fat, but they also lost fat in their lower limbs.
Even more surprising was that the relative reduction in leg fat was comparable to that observed in the trunk.
The authors also observed an improvement in insulin sensitivity, reflecting an overall metabolic benefit.
These findings therefore challenge the notion that legs affected by lipedema remain unchanged despite significant weight loss.
On the other hand, this study also shows that a reduction in volume is not necessarily accompanied by normalization of the diseased tissue.
⸻
Losing fat does not mean curing lipedema
This is probably the most important point in the entire article.
In the same study, the researchers analyzed adipose tissue following weight loss.
They found no significant changes in the associated biomarkers:
• chronic inflammation;
• fibrosis;
• abnormalities specific to the tissue affected by lipedema.
In other words, body fat may decrease even as the disease persists.
This distinction explains why some female patients continue to experience pain despite dramatic weight loss.
Lipedema is a disorder of the adipose tissue, but it is more than just a simple accumulation of fat.
⸻
Can pain be relieved with Ozempic®️ or Mounjaro®️?
That's the most common question we hear during consultations these days.
Unfortunately, the scientific community remains cautious in its response.
To date, no high-quality clinical trial has demonstrated that Ozempic®️, Wegovy®️, or Mounjaro®️ directly treat the pain associated with lipedema.
On the other hand, a few exploratory studies are opening up interesting possibilities.
A small study published in 2025 followed five women with lipedema who also had insulin resistance.
These patients were treated for several months with exenatide, another drug in the GLP-1 agonist class.
The researchers observed:
• a reduction in pain reported by patients;
• an improvement in several functional symptoms;
• a reduction in the thickness of subcutaneous fat tissue as measured by ultrasound.
These results are encouraging, but they must be interpreted with great caution.
The study involved only five patients.
All of them had insulin resistance.
Some had also made changes to their diet and physical activity.
Finally, the drug under study was neither semaglutide (Ozempic®️ or Wegovy®️) nor tirzepatide (Mounjaro®️).
As of today, this publication therefore represents a research hypothesis, but certainly not proof that GLP-1 treatments cure the pain associated with lipedema.
⸻
Why do some women's legs get much thinner while others' hardly do at all?
This is probably one of the most frustrating aspects of this disease.
Two patients can lose exactly the same number of kilograms and still achieve completely different results.
This variability is likely due to several factors.
The severity of associated obesity plays a major role.
In a woman who is significantly overweight, part of the volume of her legs is often made up of “classic” fat, which responds better to weight loss.
Conversely, when a woman is close to her ideal weight and primarily has lipedema, the reduction in volume may be more limited.
There are probably other factors at play:
• the stage of lipedema;
• the duration of the condition;
• the presence of fibrosis;
• the location of fat deposits;
• the rate of weight loss;
• the preservation of muscle mass;
• physical activity;
• hormonal and genetic factors.
That is why it is currently impossible to accurately predict the course of a given patient's condition.
⸻
Why does the upper body sometimes lose weight faster than the legs?
Many female patients find themselves in this situation.
After several months of treatment, they find that:
• their faces have become slimmer;
• their waists have become smaller;
• their chests have lost volume;
…but their legs remain relatively thick.
In reality, that doesn't necessarily mean that the legs haven't changed.
Often, they also decrease, but to a lesser extent.
As the torso becomes slimmer, the contrast between the upper and lower body becomes more noticeable.
Some patients then feel as though their lipedema is getting worse, when in fact it is simply a change in their body proportions.
This is one of the reasons why it’s better to compare photos taken under the same conditions rather than relying solely on the mirror or the number on the scale.
⸻
Can losing 40 or 50 kg make the pain go away?
Once again, the studies provide a nuanced answer.
A study involving 13 female patients who underwent bariatric surgery is particularly interesting.
On average, these women had lost more than fifty kilograms.
Despite this significant weight loss, the characteristic pain associated with lipedema persisted in a large number of them.
This observation serves as a reminder that weight loss—even significant weight loss—is not always enough to eliminate the specific symptoms of the disease.
Some patients also describe:
• pain upon touch;
• a sensation of heavy legs;
• an increased tendency to bruise;
• painful fatty nodules;
• persistent fibrosis.
Of course, that doesn't mean that weight loss is pointless.
On the contrary, it often improves cardiovascular health, reduces stress on the joints, makes it easier to get around, and lowers the risk of many obesity-related diseases.
However, it is important to understand that this, on its own, is not a curative treatment for lipedema.
⸻
What kind of returns can we reasonably expect?
For a patient with lipedema associated with being overweight or obese, medically supervised weight loss can provide numerous benefits.
In particular, we can hope for:
• a decrease in total body weight;
• a reduction in limb volume in some patients;
• an improvement in diabetes or insulin resistance, when present;
• a reduction in mechanical stress on the knees, hips, and ankles;
• improved walking ability and daily mobility;
• a better quality of life.
On the other hand, it's important to have realistic expectations.
Pain, fibrosis, tenderness, or bruising may persist despite significant weight loss.
The success of a treatment should therefore not be judged solely by the number on the scale.
Quality of life, mobility, pain, and the clinical examination are just as important.
Should you lose weight before lipedema surgery?
This is a question that comes up very often during consultations.
The answer depends primarily on each patient's individual situation.
When excess weight or obesity is associated with lipedema, medically supervised weight loss can offer several benefits before considering surgery.
In particular, it can:
• improve control of diabetes or insulin resistance;
• reduce anesthetic risk;
• facilitate postoperative recovery;
• reduce mechanical stress on the joints;
• allow for better assessment of fat distribution.
On the other hand, waiting until you’ve achieved the ideal weight loss before undergoing surgery isn’t always justified.
Some patients have severe lipedema despite having a weight close to normal. For these patients, their daily suffering is directly linked to the condition itself, not to obesity.
Conversely, other patients suffer from associated obesity that needs to be addressed before discussing a possible procedure.
Each decision must therefore be made on a case-by-case basis.
⸻
Do Ozempic®️, Wegovy®️, or Mounjaro®️ replace lipedema surgery?
No.
To date, no drug treatment has been shown to be a substitute for surgery when surgery is indicated.
These medications can help:
• significant weight loss;
• improved metabolism;
• a partial reduction in limb volume in some patients.
But they do not remove the pathological fatty tissue, as specialized lipedema surgery can.
Nor do they reverse established fibrosis or structural abnormalities in adipose tissue.
In some patients, weight loss achieved through medical treatment can even help better identify the areas that are truly associated with lipedema and optimize the surgical plan.
These are not, therefore, two opposing approaches, but rather two tools that can be complementary depending on the situation.
⸻
What factors should you keep an eye on while losing weight?
The number shown on the scale tells only part of the story.
To properly assess the progression of lipedema, several factors should be monitored regularly.
Body Measurements
Measure the circumference:
• waist;
• hips;
• thighs;
• knees;
• calves;
• ankles.
These measurements are often more informative than weight alone.
⸻
The Photographs
Photographs taken:
• in the same position;
• with the same lighting;
• at the same angle;
• at regular intervals,
allow us to view changes in a much more objective way.
⸻
Pain
The volume does not always correlate with symptoms.
Some patients find that their legs become thinner while still remaining painful.
Others quickly feel a real sense of relief.
It is therefore helpful to regularly assess:
• spontaneous pain;
• pain upon touch;
• a sensation of heavy legs;
• fatigue in the lower limbs.
⸻
Mobility
Treatment is effective when it also improves daily life.
For example:
• walk longer;
• climb stairs more easily;
• stand without prolonged pain;
• resume physical activity.
These improvements are often more valuable than simply losing weight.
⸻
Muscle mass
This is probably one of the most important points.
Treatments such as Ozempic®️, Wegovy®️, or Mounjaro®️ can lead to a loss of muscle mass along with fat loss, especially when protein intake is insufficient or physical activity is limited.
However, in patients with lipedema, muscle mass plays a key role:
• It improves joint stability;
• It promotes venous and lymphatic return;
• It helps maintain mobility;
• It increases energy expenditure at rest.
During a weight-loss program, it is therefore recommended that you:
• Maintain an adequate protein intake;
• Engage in regular, age-appropriate physical activity;
• Incorporate strength training whenever possible.
Preserving muscle mass is just as important as losing fat.
⸻
What are the side effects of GLP-1 therapies?
Like any medication, GLP-1 agonists can cause side effects.
The most common are digestive:
• nausea;
• vomiting;
• constipation;
• diarrhea;
• abdominal pain;
• a very strong feeling of fullness.
These effects often gradually subside over the course of the first few weeks.
On the other hand, very rapid weight loss can lead to:
• muscle wasting;
• nutritional deficiencies;
• severe fatigue if food intake becomes insufficient.
That is why these treatments must always be prescribed and monitored by a doctor.
They should never be used simply for cosmetic purposes or purchased outside the medical system.
⸻
What happens when you stop taking Ozempic®️ or Mounjaro®️?
That's a crucial question.
Studies on obesity show that some patients gradually regain weight after stopping treatment when no maintenance strategy is implemented.
This serves as a reminder that these medications are not a “cure” that lasts just a few weeks.
They are part of a comprehensive care plan that combines:
• a balanced diet;
• regular physical activity;
• medical care;
• and, when necessary, specialized treatment for lipedema.
⸻
In summary
Treatments such as Ozempic®️, Wegovy®️, and Mounjaro®️ represent a major advance in the management of obesity.
In some women with lipedema, these treatments can also reduce the volume of the legs and arms, particularly when there is associated excess weight.
However, current scientific evidence shows that lipedema does not automatically disappear with weight loss.
The disease is more complex than just excess fat.
Pain, tenderness, fibrosis, or body disproportion may persist despite significant weight loss.
These treatments are therefore not a substitute for specialized care, compression therapy when indicated, appropriate physical activity, or—for some patients—a discussion of surgical treatment.
The goal should not be merely to lose weight, but to achieve lasting improvements in quality of life, mobility, symptoms, and overall health.
⸻
Frequently Asked Questions (FAQ)
Can Ozempic®️ cure lipedema?
No. Current scientific evidence shows that it can promote weight loss and sometimes reduce the size of the affected limbs, but it does not cure lipedema.
⸻
Is Mounjaro®️ more effective than Ozempic®️?
No study has directly compared these two treatments in patients with lipedema. The differences observed primarily concern weight loss in obesity, not the specific treatment of lipedema.
⸻
Why do my legs still look big even though I've lost a lot of weight?
Lipedema is a chronic condition affecting adipose tissue. Even after significant weight loss, some of the tissue abnormalities, fibrosis, and pain may persist.
⸻
Does Ozempic®️ relieve pain?
To date, no large-scale study has concluded that GLP-1 therapies directly treat lipedema pain. Some findings are encouraging, but they still need to be confirmed.
⸻
Do I need to lose weight before lipedema surgery?
It depends on your situation. For some patients, weight loss improves the conditions for surgery. For others, surgery can be considered without waiting for significant weight loss. This decision should always be made on a case-by-case basis with a specialist.
⸻
Can Ozempic®️ be taken solely for cosmetic reasons?
No. These medications are prescription drugs intended for specific medical conditions. They should not be used solely for cosmetic purposes.
⸻
Will I gain weight again after stopping treatment?
Yes. As with many obesity treatments, weight regain is possible after discontinuation if no maintenance strategy is implemented.
⸻
When should you see a lipedema specialist?
A specialized consultation is recommended if you experience leg pain, tenderness, a tendency to bruise, a disproportion between the upper and lower body, or if you have questions about the various treatment options. A clinical evaluation allows for a separate assessment of weight, body measurements, symptoms, and any indications for medical or surgical treatment.